These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2284534)

  • 21. Plenary debate of randomized phase III trial of neoadjuvant MVAC plus cystectomy versus cystectomy alone in patients with locally advanced bladder cancer.
    Bajorin DF
    J Clin Oncol; 2001 Sep; 19(18 Suppl):17S-20S. PubMed ID: 11560966
    [No Abstract]   [Full Text] [Related]  

  • 22. [Neo-adjuvant and adjuvant chemotherapy in radical treatment].
    Bouchot O; Zerbib M
    Prog Urol; 2002 Nov; 12(5):987-97. PubMed ID: 12536923
    [No Abstract]   [Full Text] [Related]  

  • 23. Bladder cancer clinical trials.
    Lerner SP
    Urol Oncol; 2005; 23(4):275-9. PubMed ID: 16018944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Organ-preserving treatment of bladder cancer with combined radiochemotherapy: Do patients profit from additional neoadjuvant chemotherapy?].
    Diestelhorst A; Dunst J
    Strahlenther Onkol; 1999 Aug; 175(8):414-5. PubMed ID: 10481776
    [No Abstract]   [Full Text] [Related]  

  • 25. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
    Birtle AJ; Huddart RA
    BJU Int; 2006 Jun; 97(6):1348; author reply 1348-50. PubMed ID: 16686740
    [No Abstract]   [Full Text] [Related]  

  • 26. Perioperative chemotherapy for urothelial cancer: how have we made a "sow's ear" out of a chemotherapy-sensitive tumor?
    Dorff TB; Quinn DI
    Cancer; 2009 Nov; 115(22):5139-42. PubMed ID: 19645028
    [No Abstract]   [Full Text] [Related]  

  • 27. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
    Segal R; Winquist E; Lukka H; Chin JL; Brundage M; Markman BR;
    Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation.
    Sternberg CN
    Semin Oncol; 2007 Apr; 34(2):122-8. PubMed ID: 17382795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current status of bladder cancer protocols in the EORTC Genito-Urinary Group.
    Denis L; Pavone-Macaluso M; De Pauw M
    Prog Clin Biol Res; 1984; 162B():429-39. PubMed ID: 6390450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant chemotherapy in advanced bladder cancer. Italian Uro-Oncologic Cooperative Group.
    Bono AV; Benvenuti C; Reali L; Pozzi E; Gibba A; Cosciani-Cunico S; Comuzzi U; Anselmo G
    Prog Clin Biol Res; 1989; 303():533-40. PubMed ID: 2675010
    [No Abstract]   [Full Text] [Related]  

  • 31. [Adjuvant chemotherapy of infiltrating bladder cancer. A feasibility trial].
    Droz JP; Cukier J; Beurton D; Terdjman S; Théodore C; Amiel JL
    J Urol (Paris); 1985; 91(7):435-40. PubMed ID: 3910733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opportunities with combined modality therapy for selective organ preservation in muscle-invasive bladder cancer.
    Colvett KT; Althausen AF; Bassil B; Heney NM; McGovern FV; Young HH; Kaufman DS; Zietman AL; Shipley WU
    J Surg Oncol; 1996 Nov; 63(3):201-8. PubMed ID: 8944067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neo-adjuvant and adjuvant chemotherapy in locally advanced bladder cancer.
    Sternberg CN
    Acta Urol Belg; 1996 May; 64(2):33-4. PubMed ID: 8701807
    [No Abstract]   [Full Text] [Related]  

  • 34. [Adjuvant chemotherapy after cystectomy for bladder tumors staged as superior or equal to pT3].
    Schmid HP; Studer UE
    Prog Urol; 1997 Feb; 7(1):102-4. PubMed ID: 9116724
    [No Abstract]   [Full Text] [Related]  

  • 35. The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer.
    deVere White RW; Katz MH; Steinberg GD
    J Urol; 2009 May; 181(5):1994-7. PubMed ID: 19286209
    [No Abstract]   [Full Text] [Related]  

  • 36. Neoadjuvant chemotherapy in patients with invasive bladder cancer.
    Vaughn DJ; Malkowicz SB
    Urol Clin North Am; 2005 May; 32(2):231-7. PubMed ID: 15862620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Managing locally advanced bladder cancer.
    Lehmann J; Retz M; Siemer S; Kamradt J; Wullich B; Stöckle M
    Expert Rev Anticancer Ther; 2002 Dec; 2(6):656-66. PubMed ID: 12503211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant chemotherapy in bladder cancer.
    Williams G
    Prog Clin Biol Res; 1984; 153():373-80. PubMed ID: 6473405
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial.
    Goebell PJ; Otto T; Suhr J; Rübben H
    J Urol; 2002 Jul; 168(1):72-5. PubMed ID: 12050495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of high-stage bladder cancer: case for adjunctive chemotherapy.
    Walther PJ
    Semin Urol; 1993 May; 11(2):69-73. PubMed ID: 8362122
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.